Literature DB >> 21170027

IL-1β-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKβ.

Li-Chung Hsu1, Thomas Enzler, Jun Seita, Anjuli M Timmer, Chih-Yuan Lee, Ting-Yu Lai, Guann-Yi Yu, Liang-Chuan Lai, Vladislav Temkin, Ursula Sinzig, Thiha Aung, Victor Nizet, Irving L Weissman, Michael Karin.   

Abstract

Transcription factor NF-κB and its activating kinase IKKβ are associated with inflammation and are believed to be critical for innate immunity. Despite the likelihood of immune suppression, pharmacological blockade of IKKβ-NF-κB has been considered as a therapeutic strategy. However, we found neutrophilia in mice with inducible deletion of IKKβ (Ikkβ(Δ) mice). These mice had hyperproliferative granulocyte-macrophage progenitors and pregranulocytes and a prolonged lifespan of mature neutrophils that correlated with the induction of genes encoding prosurvival molecules. Deletion of interleukin 1 receptor 1 (IL-1R1) in Ikkβ(Δ) mice normalized blood cellularity and prevented neutrophil-driven inflammation. However, Ikkβ(Δ)Il1r1(-/-) mice, unlike Ikkβ(Δ) mice, were highly susceptible to bacterial infection, which indicated that signaling via IKKβ-NF-κB or IL-1R1 can maintain antimicrobial defenses in each other's absence, whereas inactivation of both pathways severely compromises innate immunity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21170027      PMCID: PMC3677078          DOI: 10.1038/ni.1976

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  46 in total

1.  Rapid TNFR1-dependent lymphocyte depletion in vivo with a selective chemical inhibitor of IKKbeta.

Authors:  Kumiko Nagashima; Vito G Sasseville; Danyi Wen; Andrew Bielecki; Hua Yang; Chris Simpson; Ethan Grant; Michael Hepperle; Gerry Harriman; Bruce Jaffee; Tim Ocain; Yajun Xu; Christopher C Fraser
Journal:  Blood       Date:  2006-01-26       Impact factor: 22.113

Review 2.  Neutrophils and immunity: challenges and opportunities.

Authors:  Carl Nathan
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

Review 3.  How neutrophils kill microbes.

Authors:  Anthony W Segal
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

4.  Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis.

Authors:  Vladislav Temkin; Qiquan Huang; Hongtao Liu; Hiroyuki Osada; Richard M Pope
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

5.  Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation.

Authors:  Guobin He; Guann-Yi Yu; Vladislav Temkin; Hisanobu Ogata; Christian Kuntzen; Toshiharu Sakurai; Wolfgang Sieghart; Markus Peck-Radosavljevic; Hyam L Leffert; Michael Karin
Journal:  Cancer Cell       Date:  2010-03-16       Impact factor: 31.743

6.  Neutrophil elastase is important for PML-retinoic acid receptor alpha activities in early myeloid cells.

Authors:  Andrew A Lane; Timothy J Ley
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

7.  Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.

Authors:  R Catlett-Falcone; T H Landowski; M M Oshiro; J Turkson; A Levitzki; R Savino; G Ciliberto; L Moscinski; J L Fernández-Luna; G Nuñez; W S Dalton; R Jove
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

8.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

9.  Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1.

Authors:  D Resnitzky; L Hengst; S I Reed
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

10.  I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss.

Authors:  Maria Grazia Ruocco; Shin Maeda; Jin Mo Park; Toby Lawrence; Li-Chung Hsu; Yixue Cao; Georg Schett; Erwin F Wagner; Michael Karin
Journal:  J Exp Med       Date:  2005-05-16       Impact factor: 14.307

View more
  65 in total

Review 1.  NF-κB and STAT3 - key players in liver inflammation and cancer.

Authors:  Guobin He; Michael Karin
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

2.  NF-κB inhibitor targeted to activated endothelium demonstrates a critical role of endothelial NF-κB in immune-mediated diseases.

Authors:  Bettina Sehnert; Harald Burkhardt; Johannes T Wessels; Agnes Schröder; Michael J May; Dietmar Vestweber; Jochen Zwerina; Klaus Warnatz; Falk Nimmerjahn; Georg Schett; Stefan Dübel; Reinhard Edmund Voll
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-23       Impact factor: 11.205

3.  Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2 V617F Mice.

Authors:  Wei Wang; Wenli Liu; Trevor Fidler; Ying Wang; Yang Tang; Brittany Woods; Carrie Welch; Bishuang Cai; Carlos Silvestre-Roig; Ding Ai; Yong-Guang Yang; Andres Hidalgo; Oliver Soehnlein; Ira Tabas; Ross L Levine; Alan R Tall; Nan Wang
Journal:  Circ Res       Date:  2018-11-09       Impact factor: 17.367

4.  Interleukin 1 receptor (IL-1R1) activation exacerbates toxin-induced acute kidney injury.

Authors:  Jamie R Privratsky; Jiandong Zhang; Xiaohan Lu; Nathan Rudemiller; Qingqing Wei; Yen-Rei Yu; Michael D Gunn; Steven D Crowley
Journal:  Am J Physiol Renal Physiol       Date:  2018-05-23

5.  Fracture initiates systemic inflammatory response syndrome through recruiting polymorphonuclear leucocytes.

Authors:  Haipeng Li; Jia Liu; Jianhua Yao; Jianfeng Zhong; Lei Guo; Tiansheng Sun
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

6.  Streptolysin O Induces the Ubiquitination and Degradation of Pro-IL-1β.

Authors:  Dóra Hancz; Elsa Westerlund; Christine Valfridsson; Getachew Melkamu Aemero; Benedicte Bastiat-Sempe; Pontus Orning; Egil Lien; Michael R Wessels; Jenny J Persson
Journal:  J Innate Immun       Date:  2019-03-19       Impact factor: 7.349

7.  Cell-selective inhibition of NF-κB signaling improves therapeutic index in a melanoma chemotherapy model.

Authors:  Thomas Enzler; Yasuyo Sano; Min-Kyung Choo; Howard B Cottam; Michael Karin; Hensin Tsao; Jin Mo Park
Journal:  Cancer Discov       Date:  2011-11       Impact factor: 39.397

8.  JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation.

Authors:  Ben Lu; Daniel J Antoine; Kevin Kwan; Peter Lundbäck; Heidi Wähämaa; Hanna Schierbeck; Melissa Robinson; Marieke A D Van Zoelen; Huan Yang; Jianhua Li; Helena Erlandsson-Harris; Sangeeta S Chavan; Haichao Wang; Ulf Andersson; Kevin J Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

Review 9.  NF-κB, inflammation, immunity and cancer: coming of age.

Authors:  Koji Taniguchi; Michael Karin
Journal:  Nat Rev Immunol       Date:  2018-01-22       Impact factor: 53.106

10.  Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency.

Authors:  Enrica Ek Tan; Richard A Hopkins; Chrissie K Lim; Saumya S Jamuar; Christina Ong; Koh C Thoon; Mark Ja Koh; Eun Mong Shin; Derrick Wq Lian; Madhushanee Weerasooriya; Christopher Zw Lee; Andreas Alvin Pumomo Soetedjo; Chang Siang Lim; Veonice B Au; Edmond Chua; Hui Yin Lee; Leigh Ann Jones; Sharmy S James; Nivashini Kaliaperumal; Jeffery Kwok; Ee Shien Tan; Biju Thomas; Lynn Xue Wu; Lena Ho; Anna Marie Fairhurst; Florent Ginhoux; Adrian Kk Teo; Yong Liang Zhang; Kok Huar Ong; Weimiao Yu; Byrappa Venkatesh; Vinay Tergaonkar; Bruno Reversade; Keh Chuang Chin; Ah Moy Tan; Woei Kang Liew; John E Connolly
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.